Fundraise

Auvi Labs raises $1.4M to track dialysis blood flow

What's the deal? Illinois-based Auvi LabsDealroom has a profile for this one. Try Dealroom → has raised about $1.4 million, backed by Memphis medical-device investment firm Heinz VenturesDealroom has a profile for this one. Try Dealroom →. The startup makes a wearable device that helps people with dialysis and other chronic conditions track blood flow, and the funding comes with a pilot to test on 20 patients.

Who's behind it? Chief executive officer and co-founder Rishab Veldur, an electrical engineer, built the product with vascular surgeon Richie Li, software engineer Satyansh Yeluri, and primary care physician Kevin Volkema. They met as students at the University of Illinois in Champaign.

What's the endgame? Auvi's device, Beacon, uses ultrasound to detect problems with dialysis access before they turn serious. The company is preparing for the 20-patient pilot and has said it aims for a 2028 market launch.

What could go wrong? The raise is an early validation step, not proof of a working product. Beacon still needs clinical results and regulatory progress, and rivals are chasing the same problem; the University of Maryland's VASPatch won $200,000 in awards in October to advance toward patient testing.

The signal: Dialysis access failure can disrupt treatment, making it a clinically meaningful target for wearables. For Auvi, pilot data and regulatory milestones — not the funding itself — will decide whether it reaches market.

Read more: dailymemphian.com

Image credit: "The dilysis unit of IGH" by Bhakua, licensed under CC BY 2.0

More top stories